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Objective. To optimise the use of freeze/thaw testicular immotile spermatozoa from nonobstructive azoospermia patients and to
analysetheoutcomeofintracytoplasmicsperminjection(ICSI)ofsuchspermatozoa.Methods.Testicularspecimenswereretrieved
and cryopreserved from forty patients with nonobstructive azoospermia and underwent one cycle with thawed spermatozoa
(Group I) that led to pregnancy in sixteen cases. Twenty-four patients of group I underwent treatment with the same batch of
thawed spermatozoa (Group II). For the ﬁrst ICSI attempt, injection was performed when motile spermatozoa were found. In
group II, injection was performed when maximum motility was reached. We compared mean of fertilization rate, embryo quality,
clinical pregnancy rate and embryo implantation rate. Results. The mean percentage of motility was signiﬁcantly higher in the
group II than in the group I (18, 6 versus 8, 2). Group I showed a signiﬁcant decrease in fertilization rates when compared with
cryopreserved testicular spermatozoa in group II (54% versus 72%, P<0.05). No diﬀerence was noted between the cleavage
rate, embryo quality, clinical pregnancy rates and implantation rates among group II and I. Conclusion. Fecundation rate can be
signiﬁcantly improved after in-vitro culture and sperm selection of frozen-thawed immotile testicular spermatozoa in patients
with nonobstructive azoospermia.
1.Introduction
It has been shown that the combination of human testicular
sperm biopsy and intracytoplasmatic sperm injection (ICSI)
is an eﬃcient method for the treatment of male-factor
infertility caused by azoospermia [1–4]. The successful use
of testicular sperm extraction (TESE) procedures with ICSI
led to the use of cryopreserved-thawed spermatozoa. The
addition of sperm cryopreservation is valuable as it may
reduce the number of procedures required for pregnancy
success, and repeated testicular biopsies can then be avoided
[5]. It seems that comparable success may be achieved with
frozen-thawedandfromtestisspermatozoa[6–8].Ithasbeen
also reported that the motility of testicular spermatozoa can
be improved after “in vitro” culture [7, 9, 10], although
it is not known whether implantation and pregnancy rates
are aﬀected from such a practice [11]. Furthermore, it has
also been observed [7] that the number of progressively
motile spermatozoa was signiﬁcantly increased after 72h
of culture, even if the total number of motile spermatozoa
remained constant. Konc et al. [12] showed that condition
of injected testicular spermatozoa has inﬂuence to embryo
development, and even frozen/immotile testicular spermato-
zoa are able to induce/support fertilization and early embryo
development. However, only limited data available connect-
edwiththeeﬃcacyofICSIcarriedoutwithfrozennonmotile
testicular spermatozoa.
The aim of this study was to optimise the use of freeze/
thaw testicular immotile spermatozoa from nonobstructive
azoospermia (NOA) patients and to analyse the outcome of
intracytoplasmic sperm injection (ICSI-TESE) of such sper-
matozoa.Theoutcomemeasuresstudiedandcomparedwere
fertilization rate, embryo cleavage rate, clinical pregnancy
rate and implantation rate.2 ISRN Urology
2.MaterialandMethods
2.1. Patients. The data of sixty-four TESE-ICSI cycles per-
formed in our centre in patients with NOA were evaluated
prospectively.Westudiedfortycouplesinwhichthehusband
wasdiagnosedashavingnonobstructiveazoospermia(NOA)
and only immotile testicular sperm cells were isolated by
testicular sperm extraction (TESE). Testicular specimens
wereretrievedandcryopreservedandeachcoupleunderwent
an ICSI cycle with thawed spermatozoa (Group I) that led to
pregnancy in sixteen cases. Twenty-four patients of Group
I subsequently underwent a consecutive cycle, which used
frozen-thawed sperm that were retrieved in the original
TESE procedure but were cryopreserved and stored until use
(Group II).
For the ﬁrst ICSI attempt (Group I), injection was per-
formed when motile spermatozoa were found. In most cases,
viable sperm began to twitch after 2–4 hours in culture,
and these cells were selected for ICSI. In all the twenty-four
samplesofGroupII,oneportionofthespecimenwasthawed
the day before ICSI, and changes in postthaw motility after
2, 4, 6, 8, 12, and 24h of culture at 37◦Cw e r er e c o r d e d .I n
Group II, injection was performed when maximum motility
was reached.
2.2. Testicular Biopsy Preparation. The procedure of testic-
ular sperm biopsy was similar to what has been already
described [13] and the preparation of testicular spermatozoa
was similar to the one reported by Liu et al. [14]. Brieﬂy, the
testicular tissue was placed in a Petri dish containing 2mL
sperm medium (Origio). After extraction of the connective
tissue surrounding the seminiferous tubules with glass slides,
an inverted microscope was used to detect the presence of
spermatozoa at ×200 and ×400 magniﬁcations (Diaphot,
Nilkon). If a few spermatozoa were found, the contents of
the Petri dish were transferred to a 15mL Falcon tube. Prior
to centrifugation, the larger debris of testicular tissue was
removed from the tube, and the tube containing sperm sus-
pension was centrifuged for 5min at 300g. After centrifu-
gation, the supernatant was removed and the pellet was
r e s u s p e n d e di na b o u t1 0 0:lI V Fm e d i u m( O r i g i o ) .A1 5:l
aliquot of the sperm suspension was taken and put on a glass
slide for examination of the initial motility of these sperma-
tozoa. Motility of the spermatozoa was assessed and graded
as nonmotile, weakly shaking, and progressively motile sper-
matozoa.
2.3. Ovarian Stimulation and Retrieval of Oocytes Used for
ICSI. All female partners were stimulated using gonadot-
ropin releasing hormone agonist or antagonist, human men-
opausal gonadotropin, and human FSH. Human chorionic
gonadotropin was administered when optimal follicle devel-
opment was achieved, as evaluated by serial transvaginal
ultrasound and estrogen determinations. Oocyte retrieval
wasperformedviaatransvaginalapproachwithsonographic
guidance 36 hours after human chorionic gonadotropin
injection [7]. After oocyte retrieval, maturity of the oocytes
was evaluated under the inverted microscope at ×400.
Cumulus-oocyte complexes were collected in IVF me-
dium (COOK) and cultured for another 2 hours in the
incubator before careful denudation using hyaluronidase
(Origio). Immediately after this process, ICSI was started.
2.4. Embryo Assessment and Transfer. Fertilization was
checked 16–18h after ICSI. The fertilized oocytes were
transferred and cultured in 50mL droplets of Cleavage
(COOK)mediumcoveredbymineraloil(COOK),at37◦Cin
6% CO2,5 %O 2 and 89% N2 with maximal humidity in air.
Cleavage was assessed after 48–72h and embryo quality was
evaluated prior to transfer. Embryo quality was evaluated
on the basis of morphology and developmental stage. Em-
bryos/oocytes were classiﬁed into ﬁve categories: (1) excel-
lent, (2) good, (3) fair, (4) poor, and (5) degenerate. Embryo
withnormal morphology, whichwasbeing in adevelopmen-
tal stage appropriate for its age, was classiﬁed as transferable.
Only category 1, 2, and 3 embryos were used for transfer and
the maximum number of embryos transferred was three.
Embryo transfer was performed 48–72h after oocyte
retrieval using the Wallace catheter (The Edwards-Wallace
Embryo Replacement Catheter, Sims, Portex Ltd., Kent,
UK.).
Pregnancy was deﬁned as a spontaneous rise in a βCG
concentration at least 10 days after transfer. Clinical preg-
nancy implied the presence of an intrauterine gestational sac
and fetal heart beat on an ultrasound performed at 7 weeks
of gestation.
2.5. In Vitro Culture of Frozen-Thawed Testicular Spermato-
zoa. IVF medium (Origio) without additional supplements
was used for culture of testicular spermatozoa. A 5:l aliquot
of testicular sperm suspension was added to each 10:l
droplet of IVF medium covered under mineral oil (COOK)
and incubated at 37◦Ci na na t m o s p h e r eo f6 %C O 2.I nv i t r o
culture of testicular spermatozoa was normally carried out
without change of culture medium.
2.6. Motility of Fresh and Frozen-Thawed Spermatozoa.
Washed spermatozoa were cultured in microdroplets under
paraﬃn oil using bicarbonate-buﬀered medium containing
10% human serum in a 6% CO2 incubator at 37◦C.
Motility of frozen-thawed testicular spermatozoa was
assessed under an inverted microscope (Nikon Diaphot) at
×400 magniﬁcation. One hundred testicular spermatozoa
were counted in culture droplets for each sample. The per-
centage of nonmotile, weakly shaking, and progressively mo-
tile spermatozoa were recorded in both groups. Motility of
frozen-thawed testicular spermatozoa in Group II was
assessed at diﬀerent intervals (1, 4, 6, 8, 12, and 24h),
and injection was performed when maximum motility was
reached.
2.7. Cryopreservation and Thawing of Spermatozoa. After
preparation of testicular spermatozoa, the same volume of
cryoprotectant solution (TEST yolk buﬀer with glycerol,
CRIOSPERM) was added to the testicular sperm suspension
(volume/volume) and was gently mixed. This mixture was
kept at 4◦C for 45 minutes (in a refrigerator) and thenISRN Urology 3
Table 1: General data.
Group I Group II P value
No. of cases
No. of cycles
Female age
Male age
Days of gonadotrophin stimulation 10.5 ± 2.2 12.5 ± 3.2 NS
No. of ampoules/cycle 26.7 ± 10.1 31.7 ± 9.1 NS
Estradiol level on HCG day (pmol/L) 1395 ± 1571 1237 ± 1071 NS
Endometrial thickness (mm) 10.2 ± 2.4 9.8 ± 2.2 NS
Oocytes/cycle 11.2 ± 6.8 9.8 ± 7.6 NS
MII oocytes 377/495 (76.2%) 295/377 (78.2%) NS
NS: not statistically diﬀerent.
Valuesaremean ±SD.NS:notsigniﬁcantamongallsubgroupsbytheX2 doubleclassiﬁcationtest,Fisher’sexacttestortheStudentst-testwhereappropriated.
the pellet of dry ice (Snowpack, MG Gas Products) was
prepared. This is a modiﬁed cryopreservation method of
Nagase and Niva [15], adapted to human spermatozoa [16,
17]. After the refrigeration, we prepared the mixture pills
of 10:l and placed then on dry ice for 2 minutes. Each pill
was placed in 1.0mL vials and plugged in liquid nitrogen.
Forthawing,thevialscontainingtesticularspermatozoawere
taken out from liquid nitrogen, and some of them were
transferred into a 10mL test tube and kept in a 37◦Cw a t e r
bath for 3–5 minutes. About 5mL medium (IVF, Origio)
were added into the tube. After gentle mixing, the tube
was centrifuged at 300g for 5min. After centrifugation, the
supernatant was removed and the pellet was resuspended
in about 50:l IVF medium. The procedures of the in vitro
culture of the frozen-thawed testicular spermatozoa and the
examination of their motility were the same as the one
described above for fresh testicular spermatozoa.
2.8. Statistic. Ap a i r e dt-test was carried out to analyse the
changes of motility before and after culture of fresh and
frozen-thawed testicular spermatozoa. The chi-square test
was used to compare the outcome of ICSI with fresh and
frozen-thawed testicular spermatozoa. Probabilities <5%
were considered signiﬁcant.
3. Results
The average ages of the female and male patients were 35 +
2.9 (range 24–41) and 37.5 + 6.3 years (range 26–51). The
average ages of the female and male patients were similar in
the diﬀerent treatment groups.
A total of 40 men underwent 40 TESE procedures.The
resultof the histology of testiculartissue indicated spermato-
genic arrest in 80% of the cases. The spermatogenic arrest
occurred at a diﬀerent level of spermatogenesis (primary
spermatocytes, 23%; spermatid, 77%). Sertoli-only syn-
drome was diagnosed in 20% of the patients. Male serum
levels of FSH and testosterone were 23.4 + 12.1mIU/mL and
11.7 + 7.6nmol/L (mean + S.D.).
The main results of the treatment outcome are summa-
rized in Table 1.N od i ﬀerences were found between the two
Table 2: Motility results with frozen-thawed spermatozoa on the
moment of ICSI in both groups (Group I, when spermatozoa
reached some kind of motility and Group II, after culture, with the
peaked). Values are mean ± SD.
Time of in vitro
culture
Percentagea of spermatozoa that were motile
Group 1 Group 2
12 ± 23 . 3 ± 3
28 . 2 ± 2.5a 4 ± 5
4 — 11.8 ± 4
6 — 18.6 ± 3.6a
8— 1 5 ± 18
12 — 10 ± 5
24 — 5 ± 10
aP<0.01.
groups in the days of gonadotrophin stimulation, number
of ampoules/cycle, endometrial thickness, and estradiol level
on the day of HCG administration. The number of oocytes
retrieved did not diﬀer among Groups I-II.
We found motile spermatozoa in both sperm groups.
The mean percentage of motility was signiﬁcantly higher in
Group II (after culture, with the peaked) than in Group I
(when spermatozoa reached some kind of motility) (18,6 ±
2,5 and 8,2 ± 3,2, resp.) (P<0.01). In Group II, the motility
improved markedly on the sixth hour of culture (Table 2).
Group I showed a signiﬁcant decrease in fertilization
rates when compared with cryopreserved testicular sperma-
tozoa in Group II (54% versus 72%, P<0.05, resp.).
No diﬀerences were found in the embryo formation
between oocytes injected with frozen-thawed testicular sper-
matozoa when reached some kind of motility (Group I)
versus frozen-thawed testicular spermatozoa after culture,
(94% versus 96%) (Table 3), neither quality of embryos be-
tween both groups (2,6 versus 2,7).
Embryos generated from oocytes fertilized by ICSI using
frozen-thawed testicular spermatozoa from Group I were
transferredinto 40 patients and 16 clinical pregnancy (16/40;
40%), and 14 deliveries (14/40; 35%) with 14 babies born
wereobtained.Embryosobtainedfromoocytesinjectedwith4 ISRN Urology
Table 3: ICSI results with frozen-thawed spermatozoa on the moment of ICSI in both groups (Group I, when spermatozoa reached some
kind of motility and Group II, after culture, with the peaked). Values are mean ± SD.
Group I (n = 40) Group II (n = 24) P
Fertilization rate (%) 54 72 0.05
Range 42–75 68–92
Cleavage rate (%) 94 96 NS
Range 60–100 70–100
Grade 1,2 embryos 2,62 2,7 NS
Clinical pregnancy rate (%) 40 41,6 NS
16/40 10/24
Range 20,8 25 NS
Implantation rate (%)
Deliveries 35 37,5 NS
14/40 10/24
frozen-thawed testicular spermatozoa from Group II were
transferredinto24patients.Outofthem10becameclinically
pregnant (10/24; 41,6%) and 9 deliveries (9/24; 37,5%) with
nine babies were obtained.
No diﬀerence was noted between the clinical pregnancy
rates (40% versus 41,6%). There was no diﬀerence in
implantation rates (25 versus 20,8) among Groups II and I
(Table 3).
4. Discussion
Several authors have demonstrated that performing ICSI
with fresh or frozen spermatozoa produces similar results [7,
8, 18, 19], and that freezing does not aﬀect the spermatozoa
[20].
Schlegel et al. observed in NOA patients, that in 30–38%
of the cases the TESE procedure is unsuccessful. Thus, they
and others underline the importance of the cryopreservation
of the obtained testicular tissue in the clinical application of
TESE.
Considering these results, repeated testicular biopsies
are avoided in subsequent ICSI treatment cycles by cryop-
reservation of testicular spermatozoa in patients with NOA.
Consequently, some groups have attempted to improve the
protocols for testicular sperm freezing [5, 21, 22].
Our results support the observations of others that tes-
ticular tissue may be cryopreserved successfully without
markedlyreducingsubsequentfertilizationandimplantation
rates.
In our attempt to develop more eﬃcient strategies, in-
cluding freezing of testicular spermatozoa, we compared
fertilization rates, cleavage rates, clinical pregnancy rates
and implantation rates resulting from ICSI of frozen-thawed
immotile testicular spermatozoa incubated 2–4 hours in a
simple culture medium after thawing versus frozen-thawed
immotiletesticularspermatozoaincubated2–24hoursinthe
same simple culture medium after thawing.
Our results showed that after a few hours of culture of
fresh and frozen-thawed testicular sperm samples obtained
from patients with NOA, even without motile spermatozoa,
the motility was signiﬁcantly improved. The motility of
cultured testicular spermatozoa reached a peak around
6 hours without the need for special media or treatment.
The changes in motility patterns during in vitro culture of
testicular spermatozoa has been observed previously [7],and
practical implications of using in vitro matured testicular
spermatozoa for ICSI were also described [10, 23]. The
motility of cultured testicular spermatozoa in these cases
reached a peak around 72 hours, and the results reveal that
cryopreservation had an adverse eﬀect on the survival rate
of testicular spermatozoa, since the percentage of nonmotile
spermatozoa signiﬁcantly increased after cryopreservation
[7]. These diﬀerences may be related to the procedures used
in this study for in vitro culture and for cryopreservation of
testicular spermatozoa.
In order to improve the outcome of ICSI carried out
with nonmotile spermatozoa, various methods have been
described for the selection of the immotile but viable sper-
matozoa. These include the addition of pentoxifylline (PF),
thelasertouchtechnique,mechanicaltouch,andperforming
the hypo-osmotic swelling (HOS) test [24–27]. However, it
has been argued, that using HOS test many live spermatozoa
are to become nonviable after 30min of incubation in the
hypo- osmotic solution [27]. In addition, Casper et al. [27]
reportedlowerfertilizationrateafterusingHOStestprotocol
forICSI.Ontheotherhand,somestudiesshowedthatcAMP
phosphodiesterase inhibitors are not beneﬁcial in enhancing
fertilization rates [28] or can have a negative eﬀect on animal
oocytesand embryos.Theycancausemeiotic arrestin mam-
malian oocytes [29], poorer development of mouse embryos
[30, 31], 2-cell embryo block in some mouse strains [32,
33], or parthenogenetic activation of mouse oocytes [34].
On the basis of the ﬁndings that PF is not beneﬁcial in
enhancing fertilization rates and can be toxic for oocytes, it
was suggested that PF should be used only in strictly selected
patients [30, 31].
Conversely, it has never been described the inﬂuence of
the eﬀect of frozen-thawed human previously immotile tes-
ticular spermatozoa incubation time on intracytoplasmic
sperm injection (ICSI) outcome.
In our study, frozen-thawed testicular nonmotile sper-
m a t o z o ac u l t u r e df o rap e r i o do f6 – 8hr e s u l t e di nag r e a t e r
fertilization compared with testicular nonmotile spermato-
zoa without culture. No diﬀerences were found in embryoISRN Urology 5
cleavage and clinical pregnancy outcomes between the two
groups.
The present ﬁndings are in agreement with other studies
[35] that reported the motility of testicular spermatozoa was
enhanced or initiated after in vitro culture and testicular
biopsy culture may be an alternative to the use of motility
stimulants to obtain motile spermatozoa for intracytoplas-
mic sperm injection. These results contrast with other
reports that indicate that superior results are obtained with
fresh TESE sperm rather than with TESE sperm cryop-
reservation [36, 37]. One possibility to account for these
discrepancies is that the cryopreservation methods are vari-
able between these groups and that freeze-thaw techniques
for TESE sperm can signiﬁcantly aﬀect ICSI outcomes.
Comparative studies to optimise tissue preparation, freezing
protocols, and freezing media are rare and few attempts
have been made to deﬁne the eﬀects of cryopreservation on
testicular spermatozoa.
These data suggest that fecundation rate can be signif-
icantly improved after in vitro culture and sperm selection
offrozen-thawedimmotiletesticularspermatozoainpatients
with nonobstructive azoospermia. After all, a more rational
management of testicular samples, in the case of frozen tes-
ticular spermatozoa, even though nonmotile spermatozoa,
consists of improving sperm motility of samples by several
hours of culture, after thawing and before ICSI. Higher fer-
tilization rates with this method will produce more embryos.
Therefore, it will be better embryo selection for transfer and
embryo cryopreservation, oﬀering the possibility for further
attempts with one single sample.
Weconcludethat,althoughcryopreservationdoesimpair
motility, incubation of frozen/thawed testicular immotile
sperm in cases of nonobstructive azoospermia appears to be
beneﬁcial.
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